首站-论文投稿智能助手
典型文献
Potential of Antibody-Dependent Cellular Cytotoxicity in Acute and Recovery Phases of SARS-CoV-2 Infection
文献摘要:
Background::Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused a global pandemic that has resulted in millions of casualties. Although researchers have reported the existence of neutralizing antibodies and viral T cell immunity against SARS-CoV-2, little is known about the presence of antibody-dependent cellular cytotoxicity (ADCC) and its role in combating SARS-CoV-2 infection.Methods::Nineteen acute COVID-19 patients at the First Affiliated Hospital of Guangzhou Medical University from January to February, 2020 and 55 recovery COVID-19 patients at the Second Peoples Hospital of Changde City from February, 2020 to February, 2021 were recruited in this study. Longitudinal plasma samples were collected. A virus-specific ADCC assay was performed to study the COVID-19 plasma samples. The correlations between ADCC and total IgG titer, including anti-RBD, anti-N, and neutralizing antibody titer were analyzed.Results::A high level of ADCC with 0.86% of IFN-γ +CD107a + NK cells induced by anti RBD antibodies and with 0.54% of IFN-γ +CD107a + NK cells induced by anti N antibodies was observed. This activity peaked at 3 weeks after disease onset with 1.16% and 0.63% of IFN-γ +CD107a + NK cells induced by anti RBD and anti N antibodies respectively, declined to 0.32% and 0.32% of IFN-γ +CD107a + NK cells respectively after more than 2 months, and persisted for 12 months after disease onset. The ADCC did not aggravate the severity of COVID-19 in terms of sequential organ failure assessment, although ADCC decreased with the age of COVID-19 patients. Interestingly, ADCC response is not correlated with neutralizing antibody titer or total IgG titers against S protein RBD and N protein in acute patients. ADCC in recovered patients showed a significant correlation with anti RBD IgG titer ( R2=0.33, P < 0.001). Conclusion::Antibodies from COVID-19 patients against the N protein and S protein RBD domains could stimulate high levels of ADCC response. Our results provide evidence that vaccination should not only focus on neutralizing antibodies but also binding antibodies that may facilitate the antiviral function of ADCC, especially in the elderly.
文献关键词:
Antibody-dependent cell cytotoxicity;Aged immunity;Anti-viral immunity;SARS-CoV-2;Severity
作者姓名:
Cui Tingting;Huang Mingzhu;Su Xiaoling;Lin Zhengfang;Zhong Jiaying;Yang Xiaoyun;Wang Zhongfang
作者机构:
The State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou 510180, China
引用格式:
[1]Cui Tingting;Huang Mingzhu;Su Xiaoling;Lin Zhengfang;Zhong Jiaying;Yang Xiaoyun;Wang Zhongfang-.Potential of Antibody-Dependent Cellular Cytotoxicity in Acute and Recovery Phases of SARS-CoV-2 Infection)[J].感染性疾病和免疫(英文),2022(02):74-82
A类:
Peoples,Changde,+CD107a
B类:
Potential,Antibody,Dependent,Cellular,Cytotoxicity,Acute,Recovery,Phases,SARS,CoV,Infection,Background,Severe,acute,respiratory,syndrome,coronavirus,caused,global,pandemic,that,resulted,millions,casualties,Although,researchers,have,reported,existence,neutralizing,antibodies,immunity,against,little,known,about,presence,antibody,dependent,cellular,cytotoxicity,ADCC,its,role,combating,infection,Methods,Nineteen,patients,First,Affiliated,Hospital,Guangzhou,Medical,University,from,January,February,recovery,Second,City,were,recruited,this,study,Longitudinal,plasma,samples,collected,specific,assay,was,performed,correlations,between,total,IgG,including,RBD,analyzed,Results,high,IFN,NK,cells,induced,by,observed,This,activity,peaked,weeks,after,disease,onset,respectively,declined,more,than,months,persisted,did,not,aggravate,severity,terms,sequential,organ,failure,assessment,although,decreased,age,Interestingly,response,correlated,titers,protein,recovered,showed,significant,Conclusion,Antibodies,domains,could,stimulate,levels,Our,results,provide,evidence,vaccination,should,only,focus,but,also,binding,may,facilitate,antiviral,function,especially,elderly,Aged,Severity
AB值:
0.490494
相似文献
Genomic Epidemiology of Imported Cases of COVID-19 in Guangdong Province, China, October 2020 – May 2021
LIANG Dan;WANG Tao;LI Jiao Jiao;GUAN Da Wei;ZHANG Guan Ting;LIANG Yu Feng;LI An An;HONG Wen Shan;WANG Li;CHEN Meng Lin;DENG Xiao Ling;CHEN Feng Juan;PAN Xing Fei;JIA Hong Ling;LEI Chun Liang;KE Chang Wen-Guangdong Provincial Key Laboratory of Virology,Institute of Medical Microbiology,Jinan University, Guangzhou 510632,Guangdong,China;Guangzhou National Laboratory,Guangzhou 510700,Guangdong, China;Guangdong Provincial Center for disease control and prevention,Guangdong Workstation for Emerging Infectious Disease Control and Prevention,Guangzhou 511430,Guangdong,China;Shantou University Medical College,Shantou 515041,Guangdong,China;Guangzhou Eighth People's Hospital,Guangzhou 510030, Guangdong,China;School of public health,Sun Yat-sen University,Guangzhou 510080,Guangdong,China;School of Public Health,Southern Medical University,Guangzhou 510515,Guangdong,China;Guangzhou Mendel Genomics and Medical Technology Co.,Ltd.,Guangzhou 510535,Guangdong,China;Department of Infectious Diseases,the Third Affiliated Hospital of Guangzhou Medical University,Guangzhou 510150, Guangdong,China;Department of Medical Biochemistry and Molecular Biology,School of Medicine,Jinan University,Guangzhou 510632,Guangdong,China
A broadly neutralizing human monoclonal antibody against the hemagglutinin of avian influenza virus H7N9
Li Jingxin;Zhang Li;Bao Linlin;Wang Yuxiao;Qiu Lin;Hu Jialei;Tang Rong;Yu Huiyan;Shan Jun;Li Yan;Qin Chuan;Zhu Fengcai-Department for Vaccine Clinical Evaluation, NHC Key Laboratory of Enteric Pathogenic Microbiology, Jlangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu 210009, China;Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) & Comparative Medicine Center, Peking Union Medical Collage (PUMC); Key Laboratory of Human Disease Comparative Medicine, Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Reemerging Infectious Diseases, Beijing 100101, China;Department of Public Health, Southeast University, Nanjing, Jiangsu 210009, China;Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
Clinical significance of serum IgM and IgG levels in COVID-19 patients in Hubei Province, China ☆
Bai Zhenjiang;Li Qing;Chen Qinghui;Niu Changming;Wei Yu;Huang Hanpeng;Zhao Wei;Chen Nian;Yao Xin;Zhang Qiang;Mu Chuanyong;Feng Jian;Zhu Chuanlong;Li Zhuo;Ding Ming;Feng Binhui;Jin Chaochao;Lu Xiang;Yang Yi;Wu Shuiyan;Shu Xiaochen;Hu Lifang;Qiu Haibo;Huang YingZi-Pediatric Intensive Care Unit, Children’s Hospital of Soochow University, Suzhou, Jiangsu 215025, China;Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China;Department of Infectious Diseases, Children’s Hospital of Soochow University, Suzhou, Jiangsu 215025, China;Department of Critical Care Medicine, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210011, China;Department of Respirology, Jiangsu Province Hospital of TCM, Nanjing, Jiangsu 210046, China;Department of Respirology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, China;Department of Critical Care Medicine, Sir Run Hospital Nanjing Medical University, Nanjing, Jiangsu 211112, China;Department of Infectious Diseases, The Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 211103, China;Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 211103, China;Department of Respirology, Southeast University Zhongda Hospital, Nanjing, Jiangsu 210009, China;Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China;Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226019, China;Department of Emergency, Children’s Hospital of Nanjing Medical University, Nanjing, Jiangsu 210008, China;Department of Critical Care Medicine, Huangshi Central Hospital, Huangshi, Hubei 435002, China;Department of Oncology, Huangshi Hospital of TCM (Infectious Disease Hospital, Huangshi, Hubei 435002, China;Department of Geriatric Medicine, Sir Run Hospital Nanjing Medical University, Nanjing, Jiangsu 211112, China;Department of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, Jiangsu 215031, China;Jiangsu Key Laboratory of Neuropsychiatric Diseases and Institute of Neuroscience, Soochow University, Suzhou, Jiangsu 215031, China
A Vaccine Based on the Receptor-Binding Domain of the Spike Protein Expressed in Glycoengineered Pichia pastoris Targeting SARS-CoV-2 Stimulates Neutralizing and Protective Antibody Responses
Bo Liu;Ying Yin;Yuxiao Liu;Tiantian Wang;Peng Sun;Yangqin Ou;Xin Gong;Xuchen Hou;Jun Zhang;Hongguang Ren;Shiqiang Luo;Qian Ke;Yongming Yao;Junjie Xu;Jun Wu-Department of Microorganism Engineering,Beijing Institute of Biotechnology,Beijing 100071,China;Medical Innovation Research Division&Fourth Medical Center of the Chinese PLA General Hospital,Beijing 100853,China;Department of Neurosurgery,First Medical Center of the Chinese PLA General Hospital,Beijing 100853,China;Shenzhen Taihe Biotechnology Co.Ltd.,Shenzhen 518001,China;Institute of Physical Science and Information Technology,Anhui University,Hefei 230000,China
Seroepidemiologic study on convalescent sera from dengue fever patients in Jinghong,Yunnan
Yingshuo Ma;Man Li;Lyu Xie;Na Gao;Dongying Fan;Kaihao Feng;Yao Yao;Yong Zhou;Ziyang Sheng;Hongning Zhou;Hui Chen;Jing An-Department of Microbiology,School of Basic Medical Sciences,Capital Medical University,Beijing,100069,China;Yunnan Institute of Parasitic Diseases,Pu'er,665000,China;People's Hospital of Xishuangbanna Dai Autonomous Prefecture,Xishuangbanna,666100,China;Xishuangbanna Mental Health Center,Xishuangbanna,666100,China;Yunnan Provincial Key Laboratory of Vector-Borne Diseases Control and Research and Yunnan Provincial Collaborative Innovation Center for Public Health and Disease Prevention and Control(YPCICPHDPC),Pu'er,665000,China;Experimental Center for Basic Medical Teaching,School of Basic Medical Sciences,Capital Medical University,Beijing,100069,China
Characterization of two SARS-CoV-2 subgenomic RNA dynamics in severe COVID-19 patients
Xiaohui Zou;Shengrui Mu;Yeming Wang;Li Guo;Lili Ren;Xiaoyan Deng;Haibo Li;Jiankang Zhao;Yulin Zhang;Hui Li;Binghuai Lu;Chaolin Huang;Bin Cao-Department of Pulmonary and Critical Care Medicine,Center of Respiratory Medicine,National Clinical Research Center for Respiratory Diseases,China-Japan Friendship Hospital,Beijing,100029,China;National Center for Respiratory Medicine,Beijing,100029,China;Institute of Respiratory Medicine,Chinese Academy of Medical Sciences,Beijing,100029,China;Department of Pulmonary and Critical Care Medicine,Capital Medical University,Beijing,100069,China;NHC Key Laboratory of Systems Biology of Pathogens and Christophe Mérieux Laboratory,Institute of Pathogen Biology,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing,100176,China;Jin Yin-tan Hospital,Wuhan,430013,Hubei Province,China;Tsinghua University-Peking University Joint Center for Life Sciences,Beijing,100029,China
Nasal delivery of broadly neutralizing antibodies protects mice from lethal challenge with SARS-CoV-2 delta and omicron variants
Jia Lu;Qiangling Yin;Rongjuan Pei;Qiu Zhang;Yuanyuan Qu;Yongbing Pan;Lina Sun;Ding Gao;Cuiqin Liang;Jingwen Yang;Wei Wu;Jiandong Li;Zongqiang Cui;Zejun Wang;Xinguo Li;Dexin Li;Shiwen Wang;Kai Duan;Wuxiang Guan;Mifang Lian;Xiaoming Yang-National Engineering Technology Research Center for Combined Vaccines,Wuhan Institute of Biological Products Co.Ltd.,Wuhan,430070,China;State Key Laboratory for Molecular Virology and Genetic Engineering National Institute for Viral Disease Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing,102206,China;Center for Emerging Infectious Diseases,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan,430071,China;CDC-WIV Joint Research Center for Emerging Diseases and Biosafety,Wuhan,430071,China;Institution of Infectious Diseases,Shenzhen Bay Laboratory,Shenzhen,518107,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。